Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT06539221 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Sphingolipids in Asthma Pathogenesis

StatusUnknown
PhaseNot specified
Started2024-09-01
View on ClinicalTrials.gov ↗
Record status
This record was last updated August 6, 2024 (before its estimated September 1, 2025 completion). Its status may not reflect the trial's current state.

Amendment history

2026-09-06
minor
Trial status changed: Not Yet Recruiting → Unknown
The study aims to investigate the relationship between the small molecule metabolite sphingolipids and asthma clinical features and explore its involvement in asthma pathogenesis.
Trial Details
NCT Number NCT06539221
Lead Sponsor Peking University Third Hospital
Conditions Asthma
Enrollment 200 participants
Start Date 2024-09-01
Primary Completion 2025-09-01 (estimated)
Study Completion 2026-09-01 (estimated)
Updated on ClinicalTrials.gov 2024-08-06